OHSU launches new Entrepreneur-in-Residence program

The office of Technology Transfer and Business Development (TTBD) has recently implemented an Entrepreneur-in-Residence (EIR) program that provides support to inventor teams and to new companies that form when they license technology intellectual property from OHSU. These EIR members are veteran industry and business experts that will join the TTBD team for a 12-month time span. During this period, they will aid in identifying technologies with commercial promise, and provide OHSU researchers with real-world insights about the commercialization process. They will also provide expertise in target markets, product development, and fundraising strategies. The EIRs will spend part of their time each month on the OHSU campus to collaborate with TTBD, finding, evaluating, and supporting the launch and development of new OHSU startup companies.

The TTBD team has appointed two new EIRs to jumpstart the program. These members include:

Robert Masterson

Robert Masterson, Ph.D.
Robert Masterson‘s cultivation of innovative ideas has led to two life science startups. His entrepreneurial expertise spans product idea generation, development, and commercialization; startup business models and leadership; and presentations and messaging for investors to secure angel and venture capital backing.

Under his leadership as founder, CEO, and CSO of Tessera Diagnostics, the company attracted millions in funding to explore cancer diagnostics (now Onconome, Inc.). In 2006, he co-founded and served as CEO of medical device company Prevencio, Inc., advancing its technology through the development stage.

Richard Rylander, Jr., M.B.A.
Richard Rylander, Jr. has more than 40 years experience in pharmaceutical and biotech, covering a wide range of areas including sales, management, marketing, training, operations, market research, and IT. His ground-breaking work creating the specialty distributions systems for Tracleer® and Zavesca® became the basis for the FDA’s Risk Evaluation and Mitigation Strategies program. He is also an inventor and patent holder. His device development work in diabetes combined several technologies for a unique product.

Richard Rylander, Jr.

Having launched several Orphan drugs, Rylander is well versed in identifying unique market niches as well as dealing with managed care, pricing, reimbursement, Medicare and Medicaid. He has also created call center support systems, including a unique software system for managing high-risk patients. Rylander has been involved in multiple startups and has consulted for companies evaluating new products. He has extensive experience in contract negotiation and management, performance review systems, and incentive planning.

To see a video of TTBD’s recent Lunch & Learn presentation on “How to start a company,” presented by Masterson and Rylander, please click here.

For more information on the EIR program or to inquire about startup companies at OHSU, please contact Daphne Emerson at emersond@ohsu.edu.